INTRODUCTION

Palifermin (brand name Kepivance) is a recombinant human keratinocyte growth factor that is used to prevent and treat oral mucositis following radiation or chemotherapy.

This plasmid is designed for expressing Palifermin in E.coli expression system.

PRODUCT INFORMATION

Item No.: PPBD-135
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Palifermin
Brand Name(s): Kepivance
Classification: Recombinant protein
Amino Acid Sequence: Identical to DB00039

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Barasch A, Epstein J, Tilashalski K. Palifermin for management of treatment-induced oral mucositis in cancer patients. Biologics. 2009;3:111-6.

[2] Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem. 1996 Jun 21;271(25):15292-7.

Contact Us